TABLE 1.
Recombinant ectodomaina |
KDb |
||
---|---|---|---|
H-2Db | HLA-G | Nogo-66 | |
μm | |||
PIR-B | |||
D1–D6 | 4.0 ± 1.9c (4) | 2.4 ± 0.7 (3) | 0.57d (1) |
D1D2 | 29 ± 5 (3) | 24 ± 4 (3) | 8.5 (1) |
D3–D6 | NBe (1) | NDf | 0.80 (1) |
PIR-A | |||
D1–D6 | +g (1) | ND | 6.9 (2) |
D1D2 | ND | ND | NB (1) |
D3–D6 | ND | ND | 4.3 (2) |
a Recombinant extracellular Ig-like domains of PIR (see supplemental Fig. S1A).
b Affinity was determined from the binding data fit to a bivalent analyte model for Fc fusion proteins or to a 1:1 binding model for fusion proteins without Fc.
c Affinity values were determined from the numbers of response units with various concentrations of analytes. Data are presented as the value(s) for either a single determination, the means for two different experiments, or the means ± S.D. for three to four different experiments, the number of experiments are given in parentheses. The KD value of PIR-B–H-2Db binding was larger than that reported previously (6), possibly due partly to the fact that in our previous SPR analysis, we employed the H-2 α chain complexed with human β2m to ensure the stability of the complex, and we calculated the KD at lower concentrations of anlayte than the current analysis.
d The KD value is larger than that reported previously (13), possibly due to the difference in the assay methods: Atwal et al. (13) employed an enzyme-linked immunosorbent assay.
e NB, no binding detected.
f ND, not done.
g Binding was detected with a fixed concentration of an analyte.